Healthcare IT News: Apple on Wednesday announced Apple Watch Series 4 and, in so doing, confirmed speculation that the new device would bring ECG features approved by the U.S. Food and Drug Administration.
Apple Chief Operating Officer Jeff Williams, in fact, said today at an event in Cupertino that the company has received FDA clearance for both an atrial fibrillation-detecting algorithm and an ECG that will be built into the new Apple Watch Series 4 when it becomes available on Sept. 21.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now